Patients with augmentation doses - typically 10 rad (cGy) by X-ray three times a week for five weeks - had a survival rate 68% greater than the patients without augmentation. It seems odd to me that the hormetic level radiation is given after, not prior to the larger suppressive dose. But then, it's hard to argue with success.
Source for Figure 30 Non-Hodgkin's Lymphoma Survival: Sakamoto, Kiyohiko. Survival of stage I and II of non-Hodgkin's lymphoma treated local irradiation only or combined treatment of TBI [Total Body Irradiation] and local irradiation. Journal of JASTRO, Sept. 1997. An earlier report on the same subject with wider availability is: Sakamoto, K. and Myojin, M. Fundamental and clinical studies on tumor control by total body irradiation. American Nuclear Society Transactions, 75, 404, 1996.
No comments:
Post a Comment